Tele: 561.316.3330
Breaking Medical Device News

Monday, September 27, 2021
HomeINFINITY Angioplasty Balloon CompanyINFINITY Angioplasty Balloon Catheter: Completes 1st In Human Precision Angioplasty

INFINITY Angioplasty Balloon Catheter: Completes 1st In Human Precision Angioplasty

November 17, 2020

INFINITY Angioplasty Balloon announced today that its innovative PRECISION ANGIOPLASTY™ balloon platform – INFINITY ANGIOPLASTY BALLOON CATHETER™ has successfully completed a First-in-Human clinical trial. Recently cleared by the FDA for PTA treatment of peripheral artery disease including:

  • iliac
  • femoral
  • popliteal
  • infra-popliteal arteries
  • for the treatment of AV dialysis access

“The INFINITY catheter represents a game-changing innovation in percutaneous angioplasty balloon design and utility,” states founder and vascular surgeon, John Pigott, MD.

John A. Phillips, MD, FSCAI, an interventional cardiologist at OhioHealth Riverside Methodist, performed the first-in-human INFINITY procedure.”I am extremely pleased with the catheter delivery and to-the-mm sizing of the balloon length to the lesion, particularly in this very challenging case,” commented Dr. Phillips.  “The patient was a 60-year-old woman with highly angulated aortic bifurcation and a 78mm CTO in the distal SFA.”

The INFINITY platform is the first and only therapy to provide Precision Angioplasty™, to-the-mm sizing of balloon length to the lesion. Adopting the platform significantly reduces inventory needs and costs from dozens of SKU’s and it reduces shelf space requirements, inventory management time, and trunk stock; while delivering the assurance that the right balloon size will always be on the shelf.

“INFINITY is a highly differentiated product,”  reports CEO Gary Smith.  “This is an ideal product for both Office-Based Labs and Hospitals.”  While initially launching the INFINITY ANGIOPLASTY BALLOON CATHETER, the Company intends to follow quickly with the INFINITY DEFENDER™, a DCB platform of similar design that will assure precise delivery of a drug to the lesion site and minimize downstream and systematic effects.

Key investors: JobsOhio, ProMedica Innovations, Northwest Ohio Tech Fund II, and the Global Cardiovascular Innovation Center. Received 510(K). View here.


Medical Device News Magazine
Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Stay Connected


Don't Miss

ProSomnus® Sleep Technologies Adds John E. Remmers, MD, to Leadership Team

Dr. John E. Remmers will provide expert medical and strategic guidance on a range of initiatives, including research and development, regulatory clearances, company strategy, medical education, and clinical investigations.

Nanox to Announce Zebra Medical Vision Secures 8th 510K FDA Clearance for its Coronary Artery Calcium (CAC) Solution as Part of Its Population Health Offering

On August 10th, 2021 Nanox announced that it had entered into an acquisition agreement via merger with Zebra Medical Vision LTD.

Christopher Joyce Joins Miach Orthopaedics as VP & CFO

Christopher Joyce has joined as vice president and chief financial officer, and Kevin Sidow has been appointed to the company’s board of directors.

NGMedical GmbH Receives FDA Clearance for Its AM Titanium Lumbar Interbody BEE® PLIF

The BEE® PLIF cage has been created to benefit from additive manufacturing features. The purposefully designed honeycomb endplate design reduces the risk of subsidence, while allowing fusion.

Recombinant Technologies is Raising Capital to Roll Out a Game Changing Alzheimer’s Treatment

Recombinant Technologies is focused on treating the root cause of Alzheimer's Disease delivering a huge improvement in the quality of life of those afflicted.

Tyber Medical Reaches Agreement to Acquire CatapultMD

Once the acquisition is complete, Tyber Medical will own and operate a combined 100,000-square feet of manufacturing space between its Pennsylvania headquarters and Florida-based facilities.

Kleiner Device Labs Receives FDA Market Clearance for KG2 Surge Flow-Thru Interbody System

The system maximizes total bone graft delivery volume, better distributes graft bilaterally into the intervertebral disc space, and streamlines the implant delivery, positioning, and grafting process for TLIF and PLIF spinal fusion procedures.

Matthew Cranfill New ExtriCARE USA Director Of Clinical Services

"Matt's impressive experience and skillset easily made him our top pick," said Peter Mason, President of ExtriCARE USA.

By using this website you agree to accept Medical Device News Magazine Privacy Policy